老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
考比替尼2015年于欧盟首次获得上市授权,是高选择性、可逆的丝裂原活化蛋白激酶(MEK)1/2变构抑制剂。
所有称呼考比替尼、卡比替尼、Cobimetinib
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp